First Time Loading...

Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 24.58 USD -0.45% Market Closed
Updated: May 4, 2024

Bicycle Therapeutics PLC
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bicycle Therapeutics PLC
Cash from Operating Activities Peer Comparison

Comparables:
CNTA
EXAI
AUTL
IMCR
GNS

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash from Operating Activities
-$60.6m
CAGR 3-Years
-5%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash from Operating Activities
-$160.3m
CAGR 3-Years
-147%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Cash from Operating Activities
-£117.6m
CAGR 3-Years
-62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash from Operating Activities
-$145.6m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash from Operating Activities
£2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash from Operating Activities
£44.6m
CAGR 3-Years
-16%
CAGR 5-Years
4%
CAGR 10-Years
3%

See Also

What is Bicycle Therapeutics PLC's Cash from Operating Activities?
Cash from Operating Activities
-60.6m USD

Based on the financial report for Mar 31, 2024, Bicycle Therapeutics PLC's Cash from Operating Activities amounts to -60.6m USD.

What is Bicycle Therapeutics PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-20%

Over the last year, the Cash from Operating Activities growth was 43%. The average annual Cash from Operating Activities growth rates for Bicycle Therapeutics PLC have been -5% over the past three years , -20% over the past five years .